Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
McGrath RentCorp
MGRC
$2.81B
| $1.18M | ﹤0.01% |
16,339
+6,876
| +73% | +$505K |
|
|
AFMD
2677
DELISTED
Affimed
AFMD
| $1.17M | ﹤0.01% |
18,981
+7,068
| +59% | +$465K |
|
2678
Capital City Bank Group
CCBG
$888M
| $1.17M | ﹤0.01% |
47,471
+24,968
| +111% | +$595K |
|
|
RVNC
2679
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.17M | ﹤0.01% |
42,084
+14,786
| +54% | +$422K |
|
|
CNBKA
2680
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $1.17M | ﹤0.01% |
10,162
+752
| +8% | +$86.1K |
|
2681
PUT
Humana
HUM
$43.7B
| $1.17M | ﹤0.01% |
3,000
| – | – |
|
|
IMGN
2682
DELISTED
Immunogen Inc
IMGN
| $1.17M | ﹤0.01% |
205,696
+32,163
| +19% | +$186K |
|
2683
Tompkins Financial
TMP
$1.43B
| $1.16M | ﹤0.01% |
14,389
-837
| -5% | -$64.9K |
|
2684
CALL
International Flavors & Fragrances
IFF
$20.2B
| $1.16M | ﹤0.01% |
+8,700
| New | +$1.28M |
|
2685
Primoris Services
PRIM
$4.58B
| $1.16M | ﹤0.01% |
47,356
+27,000
| +133% | +$725K |
|
2686
CBIZ
CBZ
$2.99B
| $1.16M | ﹤0.01% |
35,825
+22,015
| +159% | +$716K |
|
|
NVEE
2687
DELISTED
NV5 Global
NVEE
| $1.16M | ﹤0.01% |
46,972
+18,108
| +63% | +$446K |
|
2688
ATN International
ATNI
$366M
| $1.16M | ﹤0.01% |
24,713
+4,731
| +24% | +$214K |
|
|
SIC
2689
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $1.15M | ﹤0.01% |
79,937
+79,538
| +19,934% | +$1.01M |
|
2690
CALL
PENN Entertainment
PENN
$2.75B
| $1.15M | ﹤0.01% |
15,900
| – | – |
|
2691
Interparfums
IPAR
$3.99B
| $1.15M | ﹤0.01% |
15,367
-2,887
| -16% | -$211K |
|
|
PRO
2692
DELISTED
PROS Holdings
PRO
| $1.15M | ﹤0.01% |
32,417
+18,759
| +137% | +$788K |
|
|
BZUN
2693
Baozun
BZUN
$167M
| $1.15M | ﹤0.01% |
65,517
+10,890
| +20% | +$268K |
|
2694
Milestone Pharmaceuticals
MIST
$138M
| $1.15M | ﹤0.01% |
200,688
-3,213
| -2% | -$18.1K |
|
2695
Newmark Group
NMRK
$2.66B
| $1.15M | ﹤0.01% |
80,083
+30,053
| +60% | +$387K |
|
2696
Universal Electronics
UEIC
$57.8M
| $1.15M | ﹤0.01% |
23,279
+3,629
| +18% | +$176K |
|
2697
Donnelley Financial Solutions
DFIN
$1.16B
| $1.15M | ﹤0.01% |
33,081
+8,403
| +34% | +$277K |
|
2698
CALL
Sabre
SABR
$731M
| $1.14M | ﹤0.01% |
96,400
| – | – |
|
2699
Scholastic
SCHL
$767M
| $1.14M | ﹤0.01% |
31,900
+16,200
| +103% | +$554K |
|
2700
Liberty Latin America Class C
LILAK
$1.63B
| $1.14M | ﹤0.01% |
95,239
+68,772
| +260% | +$854K |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.